Mount Sinai Secures Large NIH Grant to Study JAK Inhibition in People with Down Syndrome and AA or AD
TDD Editorial Board Member Emma Guttman-Yassky, MD, PhD, the Waldman Professor and Chair of Dermatology at Icahn Mount Sinai in New York City, has been awarded more than $4 million for a five-year National Institutes of Health (NIH) R61/R33 grant to evaluate the long-term safety, efficacy, and mechanisms of JAK inhibitors in patients with Down […]